🟢 100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 50% of ingredients have research evidence
A Label Compliance Grade

Product Label

📸

Have a supplement label? Find it here.

Upload a photo of any supplement label to search our database of 92,312 products.

Label Data

1 Capsule(s) Serving Size
60 Servings
Other Combinations Product Type
50% Evidence Coverage

Supplement Facts — Evidence Check

20 mg (100% DV)
✅ 1.4× RDA — within safe limits 📚 193 studies (Tier A: 5, B: 63)
RDA 14mg This product: 20mg UL 35mg
25 mg (25% DV)
📊 19.2× RDA — above typical dose (UL: 100 mg) 📚 113 studies (Tier A: 3, B: 35)
RDA 1.3mg This product: 25mg UL 100mg
200 mcg (167% DV)
📊 5.7× RDA — above typical dose 📚 197 studies (Tier A: 1, B: 55)
RDA 0.035mg This product: 0.2mg
All-Day Euphoric Energy Complex
485 mg
Thermogenic Buzz Complex
135 mg
Appetite Suppression Matrix
45 mg

Other Ingredients

Gelatin Dicalcium Phosphate Magnesium Stearate

Label Claims — Verification

All Other
Structure/Function
All Other (97% of products) Structure/Function (86% of products) Nutrient (36% of products)

Target Groups

Adult (18 - 50 Years) Women (not pregnant or lactating)

Product Information

📋 Directions for Use

Suggested use: Due to the strength of Killer Bees please assess your tolerance by initially taking only 1 serving (1 capsule) upon awakening for the first 3 days. After assessment, if effects last longer than 15 hours, consider alternating dosage to every other day. Do not take within 6 hours of bedtime.

⚠️ Warnings & Precautions

Do not take within 6 hours of bedtime.

Warning: Not for use if pregnant, nursing or under the age of 18.

Warning: Not for use if pregnant, nursing or under the age of 18.

Do not use for more than 8 weeks.

Consult with a healthcare practitioner before taking this or any dietary supplement, especially if you have or suspect you may have a medical condition, including but not limited to heart, liver, kidney or thyroid disease, psychiatric or epileptic disorders, difficulty urinating, diabetes, high blood pressure, cardiac arrhythmia, recurrent headaches, enlarged prostate or glaucoma: or are taking any medications, including but not limited to MAO inhibitors, antidepressants, aspirin, non-steroidal anti-inflammatory drugs, or products containing phenylephrine, ephedrine, or pseudoephedrine; or over the counter products or other dietary supplements. Do not consume with any other stimulants, including caffeine or synaphrine, from other sources such as coffee, tea, soda or other dietary supplements or medications.

Use only as directed. Do not exceed recommended serving, as doing so may increase the risk of serious health effects and will not improve results. This product contains approximately 350 mg of caffeine per serving, and may not be appropriate for caffeine sensitive individuals. Immediately discontinue use and contact your healthcare professional if you experience any adverse reaction to this product, including but not limited to rapid heartbeat, dizziness, severe headache or shortness of breath. Discontinue use 2 weeks prior to surgery. Do not use if safety seal is broken or missing.

Keep out of reach of children.

🧪 Formulation Notes

Killer Bees is a dietary supplement engineered to amplify fat burning and help curb appetite.

CapsiAtra

The world's strongest fat burner Intense thermogenic Appetite suppression Decreased water retention

Additional Information

Store in a cool, dry place.

Facebook Twitter Instagram HyperGenetic labs

Manufactured in the USA Made from ingredients both domestic & foreign

Product Details

UPC / SKU 6 60845 91814 6
DSLD Entry Date 2023-08-23
Product Type Other Combinations
Form Capsule
DSLD ID 300250
Data Updated 2026-04-11

Research Evidence

241 Research Sources
55 Avg Quality Score
113 Meta Analysis
75 Systematic Review
32 Rct
11 Clinical Trial
3 Other
3 Regulatory Source
1 Cochrane Review
1 Narrative Review
1 Openfda Safety
A Niacin for primary and secondary prevention of cardiovascular events
Meta Analysis The Cochrane database of systematic reviews 2017
A Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases
Meta Analysis BMJ (Clinical research ed.) 2013
A Effect on cardiovascular risk of high density lipoprotein targeted drug treatments niacin, fibrates, and CETP inhibitors: meta-analysis of randomised controlled trials including 117,411 patients
Meta Analysis BMJ (Clinical research ed.) 2014
A A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk
Meta Analysis Nature medicine 2024
A Meta-analysis and imputation refines the association of 15q25 with smoking quantity
Meta Analysis Nature genetics 2010
A Genome-wide meta-analyses identify multiple loci associated with smoking behavior
Meta Analysis Nature genetics 2010
A Antidepressants for smoking cessation
Meta Analysis The Cochrane database of systematic reviews 2014
A Topical azelaic acid, salicylic acid, nicotinamide, sulphur, zinc and fruit acid (alpha-hydroxy acid) for acne
Meta Analysis The Cochrane database of systematic reviews 2020
B Assessment of the Role of Niacin in Managing Cardiovascular Disease Outcomes: A Systematic Review and Meta-analysis
Meta Analysis JAMA network open 2019
B Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis
Meta Analysis JAMA 2016
View all evidence for Niacin →

Compare Similar Products

View all Niacin products →